Skip to content

Linking Diet, Inflammation, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study

Exploring the Relationship of Diets Inflammatory, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07211321
Enrollment
1220
Registered
2025-10-07
Start date
2024-04-16
Completion date
2025-12-31
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Brief summary

Based on the analysis of dietary characteristics, gut microbiota diversity, and composition, this study investigates the relationships between the dietary inflammatory potential, gut microbiota, and sarcopenia. Furthermore, it explores the mediating role of gut microbiota in the association between the dietary inflammatory index and the risk of sarcopenia. The findings are expected to provide insights into the mechanisms through which dietary inflammation influences the development and progression of sarcopenia, and to offer a basis for dietary and nutritional interventions aimed at preventing or managing this condition.

Interventions

OTHERNo Intervention: Observational Cohort

No Intervention

Sponsors

Jianhua Ma
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Permanent residents of the community aged 60 years or older. * Continuous residence duration in the community for more than 5 years.

Exclusion criteria

* Taking medications known to affect muscle function (e.g., corticosteroids, protein supplements, muscle enhancers). * Requiring walking assistance or having severe cognitive impairment that would preclude successful completion of assessments including bioelectrical impedance analysis (BIA), gait speed measurement, and handgrip strength testing. * Presence of a cardiac pacemaker, which contraindicates BIA measurement. * Diagnosis of one or more chronic diseases that significantly limit dietary intake.

Design outcomes

Primary

MeasureTime frameDescription
The prevalence of sarcopeniaThrough study completion, an average of 1 yearThe diagnosis of sarcopenia is confirmed according to the AWGS 2019 criteria, which requires the assessment of muscle strength, physical performance, and muscle mass.
Change in absolute abundance of Faecalibacterium prausnitziiThrough study completion, an average of 1 year16S rRNA absolute quantification was used to detect the microbial composition of the fecal samples.
Dietary CharacteristicsThrough study completion, an average of 1 yearDietary data were collected using a food frequency questionnaire (FFQ) to analyze dietary patterns and nutrient intake.

Countries

China

Contacts

Primary ContactJianhua Ma Doctor of Medicine
majianhua@lzu.edu.cn0086 18993157029

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026